Plasma NEFA (non-esterified fatty acid) concentrations are elevated in patients with obesity. In the present study we first aimed to provide an integral haemodynamic profile of elevated plasma NEFAs by the simultaneous assessment of blood pressure, pulse wave velocity, FBF (forearm blood flow) and sympathetic nervous system activity during acute elevation of NEFAs. Secondly, we hypothesized that NEFA-induced vasodilation is mediated by adenosine receptor stimulation. In a randomized cross-over trial in healthy subjects, Intralipid ® was infused for 2 h to elevate plasma NEFAs. Glycerol was administered as the Control infusion. We assessed blood pressure, pulse wave velocity, FBF (using venous occlusion plethysmography) and sympathetic nervous system activity by measurement of noradrenaline and adrenaline. During the last 15 min of Intralipid ® /Control infusion, the adenosine receptor antagonist caffeine (90 µg · min −1 · dl −1 ) was administered into the brachial artery of the non-dominant arm. Compared with Control infusion, Intralipid ® increased pulse wave velocity, SBP (systolic blood pressure) and pulse pressure, as well as FBF (from 1.8 + − 0.2 to 2.7 + − 0.6 and from 2.3 + − 0.2 to 2.7 + − 0.6 ml · min −1 · dl −1 for Intralipid ® compared with Control infusion; P < 0.05, n = 9). Although in a positive control study caffeine attenuated adenosine-induced forearm vasodilation (P < 0.01, n = 6), caffeine had no effect on Intralipid ® -induced vasodilation (P = 0.5). In conclusion, elevation of plasma NEFA levels increased pulse wave velocity, SBP and pulse pressure. FBF was also increased, either by baroreflexmediated inhibition of the sympathetic nervous system or by a direct vasodilating effect of NEFAs. As the adenosine receptor antagonist caffeine could not antagonize the vasodilator response, this response is not mediated by adenosine receptor stimulation.
INTRODUCTION
The metabolic syndrome is characterized by (central) obesity, insulin resistance, glucose intolerance, dyslipidaemia and hypertension. Less well-known but consistently reported features of the metabolic syndrome include a hyperdynamic circulation and sympathetic activation [1] [2] [3] [4] . In patients with obesity and the metabolic syndrome, the plasma concentration of NEFAs (nonesterified fatty acids) is increased and evidence is accumulating that NEFAs play a central role in the clustering of the various characteristics of the metabolic syndrome [5, 6] . Therefore over the last decade several studies have explored the effect of experimental elevation of plasma NEFAs on haemodynamic parameters. Systemic administration of a triacylglycerol (triglyceride) emulsion and heparin (to activate lipoprotein lipase) is a well-validated and generally accepted model to study the effects of an acute elevation of plasma NEFAs [7] [8] [9] . Most studies agree that acute experimental elevation of NEFAs increases skeletal muscle blood flow [7, [10] [11] [12] [13] [14] . Most [7, 12, [15] [16] [17] , but not all [10, 14] , studies have shown an increase in MAP (mean arterial pressure). The reported effects of NEFAs on the activity of the sympathetic nervous system are also controversial: some studies in rats and humans have demonstrated that acute elevation of NEFAs can increase sympathetic activity [17, 18] , whereas other studies have reported the opposite [19, 20] .
Previously, we presented a novel hypothesis that explains the occurrence of a hyperdynamic circulation and sympathetic activation in individuals with the metabolic syndrome [6] . We postulated that, in these patients, elevated cytosolic concentrations of LCFA-CoA (CoA derivatives of long-chain fatty acids), the intracellular equivalent of NEFAs, inhibit the mitochondrial adenine nucleotide translocator. Consequently, intra-and extracellular concentrations of the endogenous nucleoside, adenosine, increase. Adenosine receptor stimulation induces various effects, including vasodilation in most vascular beds, renal sodium retention and activation of the sympathetic nervous system [21, 22] . As such, elevated systemic concentrations of adenosine could induce the phenotype of a hyperdynamic circulation and sympathetic activation.
The aim of the present study was 2-fold: (i) to provide an integral haemodynamic profile of elevated plasma NEFAs, and (ii) more specifically to study whether adenosine receptor stimulation is involved in the vasodilator response to NEFAs. Therefore we performed a randomized controlled cross-over study in healthy volunteers in whom systemic administration of a triacylglycerol emulsion (Intralipid ® ) was used to elevate plasma NEFAs, and we simultaneously measured FBF (forearm blood flow), intra-arterial blood pressure, pulse wave velocity and estimated the activity of the sympathetic nervous system by plasma noradrenaline measurements. In addition, caffeine, an adenosine receptor antagonist, was administered into the brachial artery of the non-dominant arm to study whether the NEFA-induced increase in FBF was due to direct adenosine receptor stimulation in the forearm vascular bed.
MATERIALS AND METHODS

Subjects
This study can be identified by ClinicalTrials.gov Identifier number NCI00184899.
The study conformed with the principles outlined in the Declaration of Helsinki and was approved by the Institutional Review Board of the Radboud University Nijmegen Medical Centre. Signed written informed consent was obtained from 15 young healthy volunteers before participation. All participants underwent a physical examination and ECG to exclude hypertension and cardiovascular or pulmonary disease. As caffeine is an effective adenosine receptor antagonist [23] , all volunteers were asked to abstain from caffeine-containing beverages for at least 24 h before the study.
Instrumentation
All experiments were performed in the morning after an overnight fast in a temperature-controlled room (23
• C) with the subjects in a supine position. After local anaesthesia (2 % xylocaine), the brachial artery of the nondominant arm was cannulated with a 20-gauge catheter (Angiocath; Becton Dickinson) for intra-arterial administration of caffeine (automatic syringe infusion pump, type STC-521; Terumo Corporation) and blood pressure recording (Hewlett Packard). FBF was recorded simultaneously in both arms by venous occlusion plethysmography using mercury-in-silastic strain gauges (Hokanson EC4), as described previously [24] . Before each recording, a wrist cuff was inflated to 200 mmHg to exclude the hand circulation.
In the main study two catheters were inserted into large antecubital veins of both arms. Intralipid ® or glycerol was administered intravenously into the dominant arm (see below). Venous blood was drawn from the nondominant arm for the determination of NEFAs, glycerol, triacylglycerol and glucose. Arterial and venous adrenaline and noradrenaline levels were assessed in blood simultaneously drawn from the brachial artery and antecubital vein of the non-dominant arm. The plasma insulin concentration was determined in arterial blood.
Validation study
In the validation study, six healthy volunteers participated. FBF was measured for 5 min during saline infusion, 30 min after cannulation of the brachial artery of the nondominant arm. Then, adenosine was administered into the brachial artery (5 µg · min −1 · dl −1 of forearm tissue) for 10 min and FBF was measured. After a 20 min wash-out period, adenosine infusion was repeated, followed 5 min later by co-infusion of caffeine (90 µg · min −1 · dl −1 ).
Main study
For the main study nine subjects were studied twice according to a randomized cross-over design. All subjects were asked to avoid excessive exercise for 24 h before the tests and to have a similar dinner the evening before both experiments. The second experiment was conducted 1 month after the first. In one experiment (the Intralipid ® experiment), subjects received an intravenous dose of a triacylglycerol emulsion (20 % Intralipid ® ; 90 ml/h) with co-administration of heparin (a bolus of 500 units, followed by continuous infusion of 0.2 units · kg −1 of body weight · min −1 intravenously) to activate lipoprotein lipase [7] . In the other experiment (the Control experiment), glycerol (50 % solution; 3 g/h) and heparin were administered to control for the elevated glycerol and heparin concentration during the Intralipid ® experiment. This design has previously been described by Krebs et al. [25] .
In both experiments, FBF was measured for 5 min during saline infusion, 30 min after cannulation. Thereafter, Intralipid ® or Control infusion was started. In both experiments, FBF was recorded for 5 min and blood was drawn for the determination of NEFAs, triacylglycerol and glycerol, 60 and 120 min after the initiation of infusion. The concentrations of insulin, adrenaline and noradrenaline were determined at t = 0 and t = 120 min. Finally, caffeine (90 µg · min −1 · dl −1 ) was administered into the brachial artery for 15 min during continuous Intralipid ® or Control infusion and with uninterrupted measurement of FBF.
During the 10 min immediately before the start of administration of Intralipid ® or Control and during the last 10 min of infusion, the heart rate was recorded by surface ECG and the blood pressure was recorded in the brachial artery. For each heartbeat, the time difference between the electrocardiographic R wave and the arrival of the pressure wave at the brachial artery was calculated and this value was averaged over these 10 min periods (MIDAC test-organiser, Radboud University Nijmegen Medical Centre). The pressure wave signal was first filtered with a low-pass filter (first order, 10 Hz), after which the local maxima (systole) and minima (diastole) were determined. Subsequently, for each pressure wave, the best line was fitted with linear regression through the rising edge between 10 and 90 % of the maximumminimum amplitude. The intersection between this line and a horizontal line (placed at the level of the diastolic value) was taken as the arrival of the blood pressure wave. As the travel distance is the same for each subject during the two experiments, this time difference can be considered as an measure of pulse wave velocity.
Analytical procedures
Blood samples for the determination of glycerol, NEFAs and triacylglycerol were collected in pre-cooled EDTAcontaining vacutainers and centrifuged at 1000 g for 10 min at 4
• C. Aliquots of plasma were immediately stored at −80
• C. NEFA (NEFA-C; Wako Chemicals), free glycerol (Roche Diagnostics) and triacylglycerol (GPO-Trinder 337B; Sigma Diagnostics) concentrations were analysed using a COBAS semi-automatic analyser (Roche Diagnostics). Due to technical problems, baseline plasma glucose levels were only determined in our laboratory in the first five experiments.
For the determination of plasma insulin, adrenaline and noradrenaline, blood was collected in pre-cooled lithiumheparin-containing vacutainers. Plasma concentrations of noradrenaline and adrenaline were determined by HPLC with fluorimetric detection [26] . Insulin was measured with an insulin-specific double antibody RIA (interassay coefficient of variation, 6.2 %). Plasma caffeine concentrations were determined by reversed-phase HPLC with UV detection set at 273 nm.
Forearm spillover of noradrenaline was estimated as previously described by Rongen et al. [27] . To correct for changes in FBF, we also calculated the appearance rate of noradrenaline [27, 28] . For these calculations, forearm fractional extraction of adrenaline was used as a substitute for noradrenaline extraction.
Statistical analysis
All values are expressed as means + − S.E.M. Baseline parameters of subjects in the validation study and main study were compared with an unpaired Student's t test, and baseline values in both experiments of the main study were compared with a paired Student's t test. Plasma concentrations of NEFAs, glycerol, triacylglycerol and insulin as well as haemodynamic parameters in both groups were analysed by repeated measures ANOVA. Forearm vascular resistance was calculated by the ratio of MAP and FBF. SPSS for Windows (release 12.0.1) was used for statistical analyses.
RESULTS
Baseline characteristics
There were no significant differences between subjects participating in the validation study and the main study. The average age was 21.2 + − 0.6 years. The baseline plasma caffeine concentration was 0.29 + − 0.17 mg/l in the validation study, and 0.21 + − 0.10 compared with 0.15 + − 0.07 mg/l in the Intralipid ® and Control studies respectively.
Validation study
Infusion of adenosine into the brachial artery of the nondominant arm for 5 min increased FBF from 1.9 + − 0.4 to 4.0 + − 0.7 ml · min −1 · dl −1 of forearm tissue during the first period of adenosine administration and to 4.1 + − 0.8 ml · min −1 · dl −1 during the second period (Figure 1A) . In the first period, adenosine infusion was continued, resulting in a further increase in FBF up to 6.3 + − 1.0 ml · min −1 · dl −1 . In the second period, caffeine was co-administered after 5 min, resulting in a decrease in FBF to 2.9 + − 0.5 ml · min −1 · dl −1 . There was a significant difference between the change in FBF during the first 5 min of caffeine administration and the change in FBF observed during continuous infusion of adenosine alone ( Figure 1B ; P < 0.01). There were no significant differences between both infusion periods with respect to blood pressure, heart rate and FBF in the control arm (results not shown). These results show that caffeine in the dose-administered arm is effective in reducing adenosineinduced vasodilation.
Main study
Haemodynamic values and plasma concentrations of NEFAs, glycerol, triacylglycerol, glucose and insulin at baseline and after 1 and 2 h of Intralipid ® or Control infusion are summarized in Table 1 . Plasma concentrations of NEFAs, triacylglycerol and glycerol increased significantly more during administration of Intralipid ® than during Control infusion. During Intralipid ® infusion a small but significant increase in plasma insulin concentration was observed (Table 1) .
Both Intralipid ® and Control infusion resulted in a significant increase in SBP (systolic blood pressure), pulse pressure and heart rate (P < 0.01 for all three parameters), whereas DBP (diastolic blood pressure) and MAP were not affected. However, increases in SBP and pulse pressure were significantly more pronounced during Intralipid ® infusion (Table 1) .
Baseline FBF was significantly higher before Control infusion than before Intralipid ® infusion. Therefore we calculated the change in FBF from baseline to express the effects of each intervention. Administration of Intralipid ® resulted in a significant increase in FBF compared with Control infusion (Figure 2 ; P < 0.05). Also, forearm vascular resistance (MAP/
The time difference between the electrocardiographic R wave and arrival of the pressure wave at the brachial artery decreased during Intralipid ® administration compared with the Control infusion ( Table 1 ), indicating that Intralipid ® administration significantly increased pulse wave velocity. We used the baseline measurements of the time difference in both groups (before any intervention) to calculate the coefficient of variation for this technique, which was 6.5 % (average of S.D. divided by the mean for each subject). For biological variables, a coefficient of variation of <10 % is considered good, and <20 % is acceptable [29] .
Administration of Intralipid ® did not have an effect on either arterial noradrenaline concentrations or calculated forearm noradrenaline spillover compared with the Control infusion. If anything, the forearm appearance rate of noradrenaline tended to increase more during the Control infusion (Table 2) .
During continuous systemic administration of Intralipid ® , infusion of caffeine into the brachial artery of the non-dominant arm did not have any effect on FBF (Figure 3 ; P = 0.5 compared with the control arm). Also during continuous Control infusion, caffeine did not affect FBF (results not shown).
DISCUSSION
The main finding of the present study is that acute elevation of NEFAs induces a haemodynamic profile consisting of increased pulse wave velocity, elevated SBP and pulse pressure and peripheral vasodilation. The observed NEFA-induced forearm vasodilation was not mediated by adenosine receptor stimulation.
Previous studies have shown that a hyperdynamic circulation is associated with several characteristics of the metabolic syndrome, although these findings have not received much attention. In adults a hyperdynamic circulation is associated with increased body mass index, triacylglycerol, glucose and insulin levels [1] . Moreover, insulin resistance and obesity are associated with increased arterial stiffness [30, 31] , which is an important cardiovascular risk marker [32] . We hypothesized that this hyperdynamic circulation is caused by increased concentrations of plasma NEFAs [6] . In obese subjects the release of NEFAs into the circulation is increased compared with lean subjects [33] . Indeed, we have demonstrated that acute experimental elevation of plasma NEFAs increased SBP and pulse pressure, but we did not observe an increased activity of the sympathetic nervous system. More specifically, we hypothesized that NEFAs would induce a hyperdynamic circulation and sympathetic activation by increased adenosine receptor stimulation [6] . In animal studies, LCFACoA have been shown to result in a concentrationdependent inhibition of the mitochondrial adenine nucleotide translocator in a physiological concentration range [34] . The adenine nucleotide translocator transports ADP from the cytosol into the mitochondrial matrix in exchange for ATP. As such, inhibition of this translocator results in increased cytosolic ADP concentrations. Consequently, according to the cytosolic adenylate kinase equilibrium, ATP and AMP concentrations increase and AMP is converted into adenosine. Indeed, it has been shown in vitro that palmitoyl-CoA inhibits the adenine nucleotide translocator and increases extramitochondrial AMP concentrations [35] . An increased intracellular adenosine concentration diminishes the transmembranous adenosine concentration gradient, thus limiting uptake of extracellular adenosine [36] . By stimulation of specific membrane-bound adenosine receptors, adenosine induces various cardiovascular and neurohumoral effects [21] , such as vasodilation and activation of the sympathetic nervous system. In addition, some studies suggest that increased systemic adenosine concentrations result in renal sodium and water retention [22] . Together, these findings suggest a role for adenosine in causing the haemodynamic changes observed in the metabolic syndrome and in response to administration of NEFAs.
It has been demonstrated previously that acute elevation of NEFAs is associated with increased forearm and leg blood flow [7, [10] [11] [12] [13] [14] . In the present study we have confirmed these findings. Subsequently, we administered caffeine, an adenosine receptor antagonist, into the brachial artery of the non-dominant arm in order to explore the role of local adenosine receptor stimulation in this NEFA-induced vasodilation. Administration of caffeine did not affect FBF in this setting, whereas at the same dose it effectively blocked adenosine-induced vasodilation. As such, the present findings do not support a role for adenosine in the vasodilator action of NEFA. Unfortunately, we did not measure endogenous plasma adenosine concentrations during administration of Intralipid ® . It is complicated to measure adenosine, because of the extremely short half life of less than 1 s [37] . It is possible to estimate the adenosine concentration by microdialysis [38] , but this technique lacks sensitivity to detect small differences in adenosine concentration.
In the present study, experimental elevation of NEFA was not associated with activation of the sympathetic nervous system. If anything, a reduction in the forearm appearance rate of noradrenaline was observed. Previous studies on this topic in healthy subjects yielded inconsistent results [17, 20] . Also, in rat models, administration of lipid emulsions has been demonstrated to either increase [18] or decrease [19] sympathetic activity. Because of these inconsistent results, it remains to be determined whether NEFAs are responsible for the reported association between the metabolic syndrome and sympathetic activation.
Interestingly, we also demonstrated that administration of Intralipid ® decreased the time difference between the electrocardiographic R wave and arrival of the pressure wave at the brachial artery. As the travel distance is the same for each subject during both experiments, this observation implies that elevation of NEFAs increases
Table 2 Plasma noradrenaline kinetics
Values are means + − S.E.M.
* P = 0.07 compared with Intralipid ® at t = 120. pulse wave velocity. This is in accordance with the results of two previous studies in which compliance after administration of a triacylglycerol emulsion was estimated by pulse wave analysis [16, 39] . A plausible explanation for the haemodynamic effects of NEFAs in our present study is that NEFAs increased pulse wave velocity by decreasing arterial compliance, which increased SBP and pulse pressure by impairing Windkessel function and by summation of the propagated and reflected pressure waves. Subsequently, baroreflexmediated inhibition of the sympathetic nervous system resulted in peripheral vasodilation. A concomitant reduction in heart rate would have been expected in this situation, but it has been demonstrated in rats [40] and humans [39] that acute experimental elevation of plasma NEFAs reduces baroreflex sensitivity, which is considered mainly to reflect vagal activity. An alternative explanation would be that NEFAs also have a direct vasodilating effect on resistance arteries, not mediated by adenosine receptor stimulation, in addition to the reduction in arterial compliance. Finally, a direct effect of Intralipid ® administration on cardiac stroke volume could have contributed to the observed increase in pulse pressure.
A number of potential limitations of our present study should be mentioned. First, the study was not blinded. Because of the different colour of the Intralipid ® emulsion and glycerol solution blinding of the present study would have been extremely complicated. However, the test sequence was randomized, and the haemodynamic and laboratory analyses were performed blinded. Secondly, plasma insulin levels were slightly, but significantly, increased following administration of Intralipid ® compared with Control. This is in accordance with the well-known effect of NEFAs on insulin-mediated glucose uptake [25] . It is unlikely that this increase in insulin concentration contributed to the increase in FBF because, in previous studies with comparable study protocols, insulin either slightly increased [10] or did not increase at all [14] , whereas blood flow increased in all studies. Moreover, insulin-mediated vasodilation was observed in previous studies only after much higher elevations of plasma insulin of approximately 10 times baseline levels [41] . Thirdly, baseline FBF was significantly higher before Control infusion than before Intralipid ® infusion. However, it is unlikely that this affected the vasomotor response to Intralipid ® or Control infusion, as there was no correlation between baseline FBF and the change in FBF in response to Intralipid ® or Control infusion (results not shown). Fourthly, in both groups, parameters of sympathetic activity tended to increase with time (Table 2) . Also, SBP and heart rate significantly increased with time in both groups. This could be stress-related, caused by discomfort of the experimental procedure. As the present study had a randomized cross-over design, it is unlikely that this would have influenced our results. Finally, it has to be realized that we studied acute and not chronic elevation of plasma NEFAs and that the plasma NEFA concentration after Intralipid ® infusion was higher than the NEFA concentration in patients with the metabolic syndrome or diabetes mellitus [42] . Thus future studies are warranted to confirm that the haemodynamic effects observed in the present study also apply to chronic and less extreme elevations in plasma NEFA concentrations.
In conclusion, acute elevation of plasma NEFA levels in healthy young subjects increased pulse wave velocity, SBP and pulse pressure, and decreased forearm vascular resistance, but did not significantly increase the activity of the sympathetic nervous system. The reduced vascular resistance could be due to baroreflex-mediated inhibition of sympathetic nerve activity. Alternatively, NEFAs could have direct vasodilator effects which, however, are not mediated by local adenosine receptor stimulation. 
